Vivo Surgical has been nominated as a finalist at the prestigious WIPO-IPOS IP for Innovation Awards 2022. The Awards are jointly organised by the Intellectual Property Office of Singapore (IPOS) and the World Intellectual Property Organization (WIPO), the IP agency of the United Nations.
In its 10th edition, the Awards celebrates Singapore enterprises that have achieved outstanding growth through their successful use of intangible assets (IA) and intellectual property (IP) to drive business expansion and value.
As a top 10 finalist of the WIPO-IPOS IP for Innovation Awards 2022, Vivo Surgical had the opportunity to pitch to a panel of distinguished judges on the use of IP to innovate and grow the business through challenging times.
“We are deeply honoured to be shortlisted alongside other exceptional companies in Singapore such as DBS Bank, Grab, Acumen Diagnostics, Allozymes, FLEXXON, Float Foods, Hydroemission, MatchMove and Polkinghornes” said Dr Kevin Koh, CEO of Vivo Surgical. “We are excited to find out about the results during IP Week 2022 and would like to wish the best of luck to all our fellow finalists!”
The WIPO-IPOS IP for Innovation Awards ceremony will be held at IP Week 2022 on 6 September 2022 in person at Marina Bay Sands Expo & Convention Centre Singapore and broadcasted live online.